|
Blood CancerCAST|Progress in NHL Treatment, Part 2 Episode
5/20/2008, Part 2
This program on non-Hodgkin lymphoma (NHL) featured John W. Sweetenham, M.D., professor of medicine, director of clinical research, Taussig Cancer Institute, Cleveland Clinic, Ohio.
This program was sponsored by The Leukemia & Lymphoma Society. In collaboration with Abrale.
[ Wed, 04 Jun 2008 13:57:00 GMT ]
|